018411832

---

February 28, 2021

Trademark Summary

The trademark application was filed by ABT Holding Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 2, 2021, and it was registered by office on August 9, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Stem cells for medical or clinical medical use
  2. Pharmaceutical compositions comprising stem cells for use in regenerative medicine
  3. Pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing and orthopedics.